Cognitive Behaviour Therapy for Abridged Somatization Disorder (Somatic Symptom Index [SSI] 4,6) patients in primary care

ISRCTN ISRCTN69944771
DOI https://doi.org/10.1186/ISRCTN69944771
Secondary identifying numbers 04/1993
Submission date
23/12/2007
Registration date
14/02/2008
Last edited
17/03/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Javier Garcia Campayo
Scientific

Hospital Miguel Servet
Avda Isabel la Catolica 1-3
Zaragoza
50.009
Spain

Phone +34 976 253621; +34 686 673302
Email jgarcamp@arrakis.es

Study information

Study designMulti-centre randomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)GP practice
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific title
Study acronymCBTASD
Study objectivesPatients randomized to cognitive behavioural therapy significantly improve in measures related to quality of life, somatic symptoms, psychopathology and health services use.
Ethics approval(s)Aragon Ethics Review Board, approved in June 2005 (ref: 05/24)
Health condition(s) or problem(s) studiedAbridged somatization disorder
InterventionThe participants will be randomely allocated to the intervention and control groups in equal numbers.

Intervention group: A manualised intervention program of cognitive behaviour therapy (10 sessions) for somatoform disorders according to Escobar (Arch Intern Med 2006; 166: 1512-18; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=16864762)

Control group: Usual care plus "Smith's norms." The general practitioners receive a short letter on recommendations (widely accepted and obtained from evidence-based medicine) to manage patients with somatoform disorders.

Duration of interventions: 3 months
Intervention typeOther
Primary outcome measureSeverity of Clinical Global Impression scale at baseline, 3 and 6 months and 1-year follow-up
Secondary outcome measuresThe following will be assessed at baseline, 3 and 6 months and 1-year follow-up:
1. Quality of life: 36-item Short Form health survey (SF-36)
2. Hamilton Depression Scale
3. Hamilton Anxiety Scale
4. Screening for Somatoform Symptoms [SOMS]
Overall study start date15/01/2008
Completion date01/07/2009

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit65 Years
SexBoth
Target number of participants140 patients
Key inclusion criteria1. Age 18-65 years
2. Fluent in Spanish language
3. Diagnosis of Abridged Somatization Disorder (SSI 4,6) according to Escobar's criteria
4. Stable pharmacological treatment during last month and the expectation to maintain it during the next three months
Key exclusion criteria1. Primary diagnosis of a psychiatric disorder different from somatization disorder
2. Severe personality disorder that interferes with adequate completion of
the intervention program
3. Impossible to attend the intervention therapy
4. Refusal to participate
Date of first enrolment15/01/2008
Date of final enrolment01/07/2009

Locations

Countries of recruitment

  • Spain

Study participating centre

Hospital Miguel Servet
Zaragoza
50.009
Spain

Sponsor information

Carlos III Institute of Health (Instituto de Salud Carlos III) (Spain)
Hospital/treatment centre

Ctra. Majadahonda - Pozuelo
Km 2 28220 - Majadahonda
Madrid
28220
Spain

Phone +34 91 5097900
Email director.cnsa@isciii.es
Website http://www.isciii.es
ROR logo "ROR" https://ror.org/00ca2c886

Funders

Funder type

Government

Carlos III Institute of Health (Madrid), Funding for Health Research for Social Security (Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias de la Seguridad Social) (Spain)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/07/2013 Yes No